Therefore, further studies of these DEP and DEPP would have profound significances for studying Elovl6 as a potential therapeutic target for many metabolic diseases such as type 2 diabetes, insulin resistance and fatty liver. This evidence concerns the gene ELOVL6 and metabolic disease.